Senseonics Q3 revenue $4.6M (+31% YoY); net loss $60.4M on non-cash fair value adjustments

Senseonics Holdings, Inc.

2022-Q3 EPS reported -$0.10 revenue$10,818,000

Revenue $4.6M vs $3.5M a year ago; U.S. revenue $1.9M (up from $0.6M), OUS $2.7M.
Net loss of $60.4M ($0.13/share) compared to net income of $42.9M ($0.10/share) in Q3 2021 due to non-cash items.
Gross profit improved to $0.8M from negative $1.2M in the prior-year period.
FY 2022 revenue guidance narrowed to $15-17M from prior $14-18M range.
Completed enrollment of pivotal 365-day sensor trial; Eversense E3 launched globally with Ascensia.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Senseonics Holdings, Inc. reported the quarter ended September 30, 2022 results: revenue $4.6 million, net income $60.4 million, or ($0.13) per share, EPS ($0.13) per share. Guidance lowered.

Period: the quarter ended September 30, 2022
Revenue: $4.6 million
Net income: $60.4 million, or ($0.13) per share
EPS: ($0.13) per share
Guidance: lowered
Result: reported results

Exact text from the filing

sensor. ● Received positive coverage decisions from Blue Cross Blue Shield of Florida and others, adding 5 million covered lives for Eversense E3 CGM. ● Generated revenue of $4.6 million in the third quarter of 2022. “Having launched the partnership with the Nurse Practitioner Group to expand access with in-home and in-office insertion options, we continue to

View on SEC.gov

Browse all earnings releases →

Senseonics Holdings, Inc. filing history →

Source: SEC EDGAR

accession 0001104659-22-115932

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.